Cell Point (India) Limited (NSE: CELLPOINT), ISIN INE0O0001013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CELLPOINT last traded at ₹19.95 (+2.31%), with a 52-week range of ₹11.70 to ₹21.10 (as of 29 Jul 2026).
Shareholding as of Mar 2026: promoters 73.06%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 59/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.